Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Comparative Study

Randomized Controlled Trial

Meta-Analysis

Research Support, U.S. Gov't, P.H.S.

Clinical Trial

Validation Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2021

2017

2016

2015

2013

2012

2011

2010

2009

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Genes, p16""[mesh_terms]

30 Results

Searching titles within these results

Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications.

S I Baithun, M Naase, A Blanes, S J Diaz-Cano

Virchows Archiv : an international journal of pathology 2001;438(3):289-97

Full Text

Abstract

Germline melanoma susceptibility and prognostic genes: a review of the literature.

DeAnn Lazovich, Katherine A Ward, Maria K Hordinsky

Journal of the American Academy of Dermatology 2013;67(5):1055-67

Full Text

Abstract

Meta-analyses of methylation markers for prostate cancer.

Danjie Jiang, Yusheng Shen, Dongjun Dai, Yan Xu, Chunjing Xu, Huangkai Zhu, Tao Huang, Shiwei Duan

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015;35(10):10449-55

Free Full Text

Abstract

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Peter B Illei, Valerie W Rusch, Maureen F Zakowski, Marc Ladanyi

Clinical cancer research : an official journal of the American Association for Cancer Research 2004;9(6):2108-13

Full Text

Abstract

The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.

Naoko Ohtani, Kimi Yamakoshi, Akiko Takahashi, Eiji Hara

The journal of medical investigation : JMI 2004;51(3-4):146-53

Free Full Text

Abstract

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.

Frederic J Kaye

Oncogene 2002;21(45):6908-14

Full Text

Abstract

Genetics in melanoma.

Shy Stahl, Eran Bar-Meir, Eitan Friedman, Eli Regev, Arie Orenstein, Eyal Winkler

The Israel Medical Association journal : IMAJ 2005;6(12):774-7

Free Full Text

Abstract

Validation of signalling pathways: Case study of the p16-mediated pathway.

Nimet İlke Akçay, Rza Bashirov, Şükrü Tüzmen

Journal of bioinformatics and computational biology 2016;13(2):1550007

Full Text

Abstract

A cancer-prone case with a background of methylation of p16 tumor suppressor gene.

Kenji Hibi, Masahiko Koike, Hiroshi Nakayama, Shinichi Fujitake, Yasushi Kasai, Katsuki Ito, Seiji Akiyama, Akimasa Nakao

Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1053-6

Full Text

Abstract

Molecular genetics of head and neck cancer.

Frank N Salamone, Lyon L Gleich

Cancer control : journal of the Moffitt Cancer Center 2003;9(5):369-78

Free Full Text

Abstract

What we could do now: molecular pathology of bladder cancer.

M A Knowles

Molecular pathology : MP 2001;54(4):215-21

Free Full Text

Abstract

Inhibition of Smad antiproliferative function by CDK phosphorylation.

Isao Matsuura, Fang Liu

Cell cycle (Georgetown, Tex.) 2006;4(1):63-6

Full Text

Abstract

Cytogenetics and molecular genetics of lung cancer.

Yasuhiro Mitsuuchi, Joseph R Testa

American journal of medical genetics 2003;115(3):183-8

Full Text

Abstract

Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women.

Simonetta Friso, Stefania Lamon-Fava, Hyeran Jang, Ernst J Schaefer, Roberto Corrocher, Sang-Woon Choi

The British journal of nutrition 2007;97(4):617-21

Full Text

Abstract

Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes.

Marco Migliaccio, Kenneth Raj, Olivier Menzel, Nathalie Rufer

Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3335-43

Full Text

Abstract

Results: 1 – 15 / 30

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Genes, p16""[mesh_terms]

Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications.

Germline melanoma susceptibility and prognostic genes: a review of the literature.

Meta-analyses of methylation markers for prostate cancer.

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.

Genetics in melanoma.

Validation of signalling pathways: Case study of the p16-mediated pathway.

A cancer-prone case with a background of methylation of p16 tumor suppressor gene.

Molecular genetics of head and neck cancer.

What we could do now: molecular pathology of bladder cancer.

Inhibition of Smad antiproliferative function by CDK phosphorylation.

Cytogenetics and molecular genetics of lung cancer.

Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women.

Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes.

Results for
""Genes, p16""[mesh_terms]